| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/07/2002 | EP1227813A1 Reverse-turn mimetics and methods relating thereto |
| 08/07/2002 | EP1227810A1 Treating cancer by increasing intracellular malonyl coa levels |
| 08/07/2002 | EP1227805A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 08/07/2002 | EP1227800A1 Osmotic controlled release drug delivery device |
| 08/07/2002 | EP1227795A2 Lipid complex of alkycyclines |
| 08/07/2002 | EP1227714A1 Method for producing metabolites from plants cultivated in soil-less medium |
| 08/07/2002 | EP1156789A4 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 08/07/2002 | EP1058679A4 Synthesis of epothilones, intermediates thereto and analogues therof |
| 08/07/2002 | EP0980379B1 Chimeric oligonucleotides and the use thereof |
| 08/07/2002 | EP0906276B1 Novel vitamin d analogues |
| 08/07/2002 | EP0839143B1 Tetralin compounds with mdr activity |
| 08/07/2002 | EP0805690B1 Method for selective methionine starvation of malignant cells in mammals |
| 08/07/2002 | EP0801649B1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 08/07/2002 | CN1362959A C10 carbamoyloxy substituted taxanes as antitumor agents |
| 08/07/2002 | CN1362958A C7 carbonate substituted taxanes as antitumor agents |
| 08/07/2002 | CN1362957A C17 heterosubustituted acetate taxanes as antitumor agents |
| 08/07/2002 | CN1362956A C7 carbamoyloxy substituted taxanes as antitumor agents |
| 08/07/2002 | CN1362955A C7 ester substituted taxanes as antitumor agents |
| 08/07/2002 | CN1362954A Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/07/2002 | CN1362953A Pyrazole compositions useful as inhibitors of ERK |
| 08/07/2002 | CN1362952A 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands |
| 08/07/2002 | CN1362947A N-cyanomethylamides as protease inhibitors |
| 08/07/2002 | CN1362884A Preventives/remedies for liver diseases |
| 08/07/2002 | CN1362881A Inflammatory mediation obtained from atractylodes lancea |
| 08/07/2002 | CN1362880A Immunomodulating polymers |
| 08/07/2002 | CN1362876A C10 heterosubstituted acetate taxanes as antitumor agents |
| 08/07/2002 | CN1362419A Schizophyllum tetrasaccharide-alkyl glycoside compound and its prepn and application |
| 08/07/2002 | CN1362409A 2-phenoxy pyrimidine derivative and its use in treating disease |
| 08/07/2002 | CN1362407A Glutarimide compound S632A3 and its prepn and application in preparing medicine for treating viral infection and tumor |
| 08/07/2002 | CN1362261A Health tonic containing rich lucid ganoderma selenium |
| 08/07/2002 | CN1362259A Application of nim extract in medicine |
| 08/07/2002 | CN1362254A Cancer-treating injection and its automatic separation process |
| 08/07/2002 | CN1362251A Orally taken Chinese medicine for treating endocrine dyscrasia |
| 08/07/2002 | CN1362225A Nano medicine of four mild ingredients and its preparation |
| 08/07/2002 | CN1362139A Nano Pingxiao medicine and its preparation |
| 08/07/2002 | CN1362105A Nano Angelicae longhui meidcine and its preparation |
| 08/07/2002 | CN1362064A Antineoplastic composite and its prepn process and use |
| 08/07/2002 | CN1362061A New medicine use of 6-methoxy-2-delta 10'-cis-heptadecene-1,4 benzoquinone |
| 08/07/2002 | CN1362060A Prepn of nano hydroxycamptothecine-dextran grain |
| 08/07/2002 | CN1362023A Vitality invigorating anticancer cracker |
| 08/07/2002 | CN1088721C Interferon conjugates |
| 08/07/2002 | CN1088710C Water soluble repamycin esters |
| 08/07/2002 | CN1088703C Water soluble of taxad alcohol derivative |
| 08/07/2002 | CN1088599C Therapeutic compositions comprising antigen or an in vivo generator comprising amino-acid serial compounds |
| 08/07/2002 | CN1088597C Uropoly acid-peptide composition and its usage |
| 08/07/2002 | CN1088582C Lipid-based carriers which can treat multiple diseases and have layered lipid componnets, their composition and use |
| 08/06/2002 | US6429303 Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same |
| 08/06/2002 | US6429295 Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it |
| 08/06/2002 | US6429287 Tumor rejection antigens; cancer diagnosis; activators of cytolysis |
| 08/06/2002 | US6429224 Use of taurolidine to treat tumors |
| 08/06/2002 | US6429223 Modified forms of pharmacologically active agents and uses therefor |
| 08/06/2002 | US6429214 Inhibitors of bone resorption |
| 08/06/2002 | US6429213 Cyclic hydroxamic acids as metalloproteinase inhibitors |
| 08/06/2002 | US6429203 Farnesyl-protein transferase inhibitors |
| 08/06/2002 | US6428788 Preferential drug delivery to tumors having interleukin receptors; side effect reduction |
| 08/06/2002 | US6428785 Local administration of therapeutically effective concentration of collagenase for therapy of prostate cancer in mammal |
| 08/06/2002 | US6428782 Non-myeloablative tolerogenic treatment |
| 08/06/2002 | CA2144327C Transcutaneous in vivo activation of photosensitive agents in blood |
| 08/06/2002 | CA2122714C Materials comprising and methods of preparation and use for ribosome-inactivating proteins |
| 08/06/2002 | CA2057010C Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
| 08/01/2002 | WO2002059609A2 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
| 08/01/2002 | WO2002059607A2 Isolation of epidermal stem cells by using the melanoma-associated chondroitin sulfate proteoglycan |
| 08/01/2002 | WO2002059558A2 Means and methods for treatment evaluation |
| 08/01/2002 | WO2002059373A2 Genes overexpressed in prostate disorders as diagnostic and therapeutic targets |
| 08/01/2002 | WO2002059361A1 Use of the slug gene or of the transcription or expression products thereof in the detection and/or treatment of cancerous cells |
| 08/01/2002 | WO2002059327A2 Sulfatases and methods of use thereof |
| 08/01/2002 | WO2002059326A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 08/01/2002 | WO2002059323A2 Aminoacyl trna synthetases |
| 08/01/2002 | WO2002059304A1 Novel g protein-coupled receptor protein and dna thereof |
| 08/01/2002 | WO2002059302A2 Regulation of human serotonin-like g protein-coupled receptor |
| 08/01/2002 | WO2002059295A1 Novel serine protease mp493 |
| 08/01/2002 | WO2002059293A2 Process and compositions for peptide, protein and peptidomimetic synthesis |
| 08/01/2002 | WO2002059291A2 Biological organism for preparing pharmaceutical compositions for treating mammals |
| 08/01/2002 | WO2002059286A2 Adenylate cyclases |
| 08/01/2002 | WO2002059283A2 Nucleic acid modification enzymes |
| 08/01/2002 | WO2002059267A2 Constitutively desensitized g protein-coupled receptors |
| 08/01/2002 | WO2002059264A2 Specific human antibodies for selective cancer therapy |
| 08/01/2002 | WO2002059256A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/01/2002 | WO2002059156A2 Therapeutic compounds structurally-linked to bacterial polypeptides |
| 08/01/2002 | WO2002059135A1 Compositions containing a ruthenium(iii) complex and a heterocycle |
| 08/01/2002 | WO2002059134A1 Transition metal complexes with proton sponges as ligands |
| 08/01/2002 | WO2002059131A1 Formulation of boronic acid compounds |
| 08/01/2002 | WO2002059130A1 Formulation of boronic acid compounds |
| 08/01/2002 | WO2002059125A1 Cyclin dependent kinase inhibiting purine derivatives |
| 08/01/2002 | WO2002059122A1 ANTI-CANCER 2,3-DIHYDRO-1H-PYRROLO[3,2-f]QUINOLINE COMPLEXES OF COBALT AND CHROMIUM |
| 08/01/2002 | WO2002059116A2 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections |
| 08/01/2002 | WO2002059113A1 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 08/01/2002 | WO2002059112A2 Pyrazole compounds useful as protein kinase inhibitors |
| 08/01/2002 | WO2002059111A2 Pyrazole compounds useful as protein kinase inhibitors |
| 08/01/2002 | WO2002059110A1 Pyrimidineamines as angiogenesis modulators |
| 08/01/2002 | WO2002059109A2 Naphthostyril derivatives and their use as inhibitors of cyclin- dependent kinases |
| 08/01/2002 | WO2002059106A1 Isoindole-imide compounds, compositions, and uses thereof |
| 08/01/2002 | WO2002059102A2 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use |
| 08/01/2002 | WO2002059083A2 Novel compounds |
| 08/01/2002 | WO2002059080A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use |
| 08/01/2002 | WO2002058775A2 Device for dilating and irradiating a vascular segment or body passageway |
| 08/01/2002 | WO2002058740A1 Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases |
| 08/01/2002 | WO2002058738A2 Use of rad51 inhibitors for p53 gene therapy |
| 08/01/2002 | WO2002058735A1 Method of preparing biological materials and preparation produced using same |
| 08/01/2002 | WO2002058729A2 Methods of inducing organ transplant tolerance and correcting hemoglobinopathies |